Phase I evaluation of the safety and pharmacokinetics of a single-dose intravenous injection of a murine monoclonal antibody against hantaan virus in healthy volunteers

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 12, 2009, Pages 5055-5059

  Rong, Xu ^a   Xiao, Yan Yang ^a   Dao, Feng Yang ^a   Chang, Yong Zou ^b   Pei, Li Gong ^a   Fan, Dian Zeng ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Wuhan Institute of Biological Products   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HANTAAN VIRUS MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADULT; ARTICLE; ASTHENIA; BLOOD SAMPLING; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HANTAVIRUS; HEADACHE; HUMAN; IMMUNOASSAY; KINETICS; MALE; NAUSEA; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; VIRUS INFECTION; VOMITING;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIVIRAL AGENTS; AREA UNDER CURVE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HALF-LIFE; HANTAAN VIRUS; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MICE; YOUNG ADULT;

EID: 71249110581     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00728-09     Document Type: Article

References (15)

1. De Clercq, E. 2005. Recent highlights in the development of new antiviral drugs. Curr. Opin. Microbiol. 8:552-560.
2. Kuus-Reichel, K., L. S. Grauer, L. M. Karavodin, C. Knott, M. Krusemeier, and N. E. Kay. 1994. Will immunogenicity limit the use, efficacy, and future development of therapeutic monoclonal antibodies? Clin. Diagn. Lab. Immunol. 1:365-372.
3. Lobo, E. D., R. J. Hansen, and J. P. Balthasar. 2004. Antibody pharmaco-kinetics and pharmacodynamics. J. Pharm. Sci. 93:2645-2668.
4. Maes, P., J. Clement, I. Gavrilovskaya, and M. Van Ranst. 2004. Hantaviruses: immunology, treatment, and prevention. Viral Immunol. 17:481-497.
5. Peters, C. J., G. L. Simpson, and H. Levy. 1999. Spectrum of hantavirus infection: hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. Annu. Rev. Med. 50:531-545.
6. Reichert, J. M., and M. C. Dewitz. 2006. Anti-infective monoclonal antibodies: perils and promise of development. Nat. Rev. Drug Discov. 5:191-195.
7. Rosenblum, M. G., J. L. Murray, T. P. Haynie, H. J. Glenn, M. F. Jahns, R. S. Benjamin, J. M. Frincke, D. J. Carlo, and E. M. Hersh. 1985. Pharmacokinetics of 111In-labeled anti-p97 monoclonal antibody in patients with metastatic malignant melanoma. Cancer Res. 45:2382-2386. (Pubitemid 15024356)
8. Saleh, M. N., M. B. Khazaeli, W. E. Grizzle, R. H. Wheeler, S. Lawson, T. Liu, C. Russel, R. Meredith, J. Schlom, and A. F. LoBuglio. 1993. A phase I clinical trial of murine monoclonal antibody D612 in patients with metastatic gastrointestinal cancer. Cancer Res. 53:4555-4562. (Pubitemid 23304379)
9. Wang, L. Y., R. R. Zheng, Z. K. Xu, M. X. Wang, and S. C. Jiang. 1988. Establishment and identification of hybridoma cell lines secreting monoclonal antibodies against hemagglutinin of HFRS virus. J. Fourth. Mil. Med. Univ. 9:20-23.
10. Wang, W., E. Q. Wang, and J. P. Balthasar. 2008. Monoclonal antibody pharmacokinetics and pharmacodynamics. Clin. Pharmacol. Ther. 84:548-558.
11. Wei, L. X., M. X. Wang, Z. K. Xu, and L. Y. Wang. 1989. Study on protection effects of MAb on HFRS virus infected suckling mice. J. MAb 5:5-10.
12. Wei, L. X., M. X. Wang, H. Zhang, and L. Y. Wang. 1990. McAbs inoculated into pregnant mice passively protected filial suckling mice from HFRS virus by transplacental passage. J. MAb 6:16-18.
13. Xu, Z. K., L. X. Wei, L. Y. Wang, H. T. Wang, and S. B. Jiang. 2002. The in vitro and in vivo protective activity of monoclonal antibodies directed against Hantaan virus: potential application for immunotherapy and passive immunization. Biochem. Biophys. Res. Commun. 298:552-558.
14. Yan, L., L. Q. Fang, H. G. Huang, L. Q. Zhang, D. Feng, W. J. Zhao, W. Y. Zhang, X. W. Li, and W. C. Cao. 2007. Landscape elements and Hantaan virus-related hemorrhagic fever with renal syndrome, People's Republic of China. Emerg. Infect. Dis. 13:1301-1306.
15. Yang, W. T., Z. K. Xu, and H. T. Wang. 2004. Detection of metabolism of anti HFRS V antibody in HFRS patients. J. Fourth. Mil. Med. Univ. 25: 1525-1527.